The Science and Technology Innovation Board Daily News on September 2nd. Today's Science and Technology Innovation Board evening news main content: State Council: vigorously develop outsourced research and development of biomedicine, digital manufacturing outsourcing; Ministry of Industry and Information Technology: planned to implement large-scale digital transformation and upgrading of equipment; Shanghai: strive to become an internationally influential live broadcast economy hub by 2026.

Focus on hot topics

Briefs:

The State Council: vigorously develop the outsourcing of biomedical research and development, digital manufacturing outsourcing, and support new models of service outsourcing such as cloud outsourcing and platform subcontracting.

The State Council Office recently issued the "Opinions on Promoting High-level Opening-up to Promote the High-quality Development of Trade in Services". The "Opinions" propose to support the development of professional services trade, expand the export of characteristic services, promote the agglomeration and development of services trade in intellectual property, geographic information, and human resources, support the improvement of international service capabilities of professional service institutions such as finance, consulting, design, certification and accreditation, law, mediation, arbitration, accounting, language, supply chain, and standardization, cultivate new growth points for trade in services, develop agricultural services trade, drive the export of agricultural supplies, agricultural machinery, agricultural technology, etc., accelerate the development of education services trade, expand high-level cooperation with globally renowned universities, and carry out high-level cooperative education in China. Accelerate the high-end development of service outsourcing, vigorously develop outsourcing of biomedical research and development, digital manufacturing outsourcing, and support new models of service outsourcing such as cloud outsourcing and platform subcontracting, further promoting the employment of key groups such as college graduates.

Ministry of Industry and Information Technology: planned to implement large-scale digital transformation and upgrading of equipment.

The Ministry of Industry and Information Technology is soliciting opinions on the draft implementation plan for the digital transformation of the light industry. It proposes to compile guidelines for the update of equipment in the light industry, and to promote the digital transformation and upgrading of key equipment and processes in industries such as home appliances, leather, papermaking, hardware products, plastic products, bicycles/electric bicycles, as well as research and development, production, and testing. It also encourages the widespread use of industrial control systems such as programmable logic controllers (PLC), distributed control systems (DCS), industrial robots, intelligent testing equipment, manufacturing execution systems (MES). It supports the upgrading of internal and external networks of enterprises, and the application of network communication technologies such as 5G, industrial optical networks, and IPv6. It also establishes and improves network security and data security protection mechanisms.

The State Tobacco Monopoly Administration: The administrative department of tobacco monopoly under the State Council has established a unified national electronic tobacco trade management platform.

The State Tobacco Monopoly Administration issued a notice on the revision and issuance of the 'Regulations on the Management of Electronic Cigarette Trading'. The notice mentioned that the competent administrative department of tobacco monopoly under the State Council will establish a unified national platform for the management of electronic cigarette trading. Enterprises that have obtained tobacco monopoly licenses for the sale of electronic cigarette nicotine raw materials, production enterprises of electronic cigarette nicotine, aerosol production enterprises, electronic cigarette production enterprises (including product production, contract processing, brand holding enterprises, etc., hereinafter referred to as electronic cigarette production enterprises), electronic cigarette wholesale enterprises (including electronic cigarette import and export enterprises), and various types of electronic cigarette market entities should conduct transactions through the platform. Imports and exports of electronic cigarette products, aerosols, and electronic cigarette nicotine should be registered on the platform in accordance with relevant regulations.

Shanghai: Strive to become an international hub for live-streaming economy by 2026. The retail sales of live-streaming e-commerce will strive to reach 600 billion yuan.

Shanghai has issued the 'Three-year Action Plan (2024-2026) to Promote the High-quality Development of the Live-streaming Economy in Shanghai'. It proposes that by 2026, the city will continue to maintain a leading position in the international development of the live-streaming economy, with a clear role in empowering the industry, a more complete industry ecosystem, stable growth in the scale of live-streaming e-commerce, diverse and scientifically structured live-streaming formats, continuous aggregation of market entities, and the establishment of an efficient and collaborative live-streaming economic ecosystem. It aims to establish sound and high-standard industry norms and regulatory mechanisms, strive to become an international hub for the live-streaming economy with global influence. The retail sales of live-streaming e-commerce will strive to reach 600 billion yuan, the scale of various types of live-streaming economy entities will continue to expand, 10 leading live-streaming platforms with national influence and international competitiveness will be developed, a number of MCN (Multi-Channel Network) organizations with large scale, strong driving force, and domestic influence will be cultivated, a number of well-known live-streaming event IP brands in China will be created, and 100 characteristic live-streaming scenes will be sorted out and released.

In-depth analysis:

Taiwan Semiconductor's cutting-edge A16 chip has received orders! Apple and OpenAI are said to have booked the first batch of production capacity.

OpenAI has released a new humanoid robot prototype called NEO designed specifically for household chores.

The Ministry of Industry and Information Technology is promoting the digital transformation of the light industry: large-scale equipment will be renovated and updated. These companies have already laid out their plans.

Announcement of the Science and Technology Innovation Board

Advanced Micro-fabrication Equipment Inc. China: Major shareholder's equity changes, Shanghai Venture Capital and Pudong New Production Investment are no longer in a concerted action relationship.

Advanced Micro-fabrication Equipment Inc. China announcement: The state-owned asset regulatory agency has decided to gratuitously transfer the 46% equity of Shanghai Pudong Science and Technology Innovation Group Co., Ltd. held by Shanghai Science and Technology Innovation Group to the State-owned Assets Supervision and Administration Commission of Pudong New Area, Shanghai. As a result, Shanghai Venture Capital and Pudong New Production Investment are no longer in a concerted action relationship. In addition, due to the dilution of the company's stock-based incentive plan and the return of shares lent by margin brokers, the equity of Shanghai Venture Capital and Pudong New Production Investment has changed by +4.4 million shares (0.72%) and +0.1 million shares (0.02%) respectively. This equity change does not involve capital sources, does not trigger a tender offer, and will not cause changes in the company's controlling shareholder or actual controller status.

Willfar Information: won the bid for State Grid Corporation's procurement project

Willfar Information announcement, the company won the bid for State Grid Corporation's 64th batch of procurement (second tendering and purchasing of marketing project measuring equipment) project in 2024, with a winning amount of 26.131 million RMB, accounting for 1.17% of the company's audited total operating income for 2023. The specific delivery batches and timing of the project are subject to on-site construction progress, and there is uncertainty about the impact on the performance of the current year in 2024.

Zhejiang Orient Gene Biotech: Wholly owned subsidiary company obtains USA CLIA laboratory qualification certification

Zhejiang Orient Gene Biotech announced that its wholly-owned subsidiary in the United States, Texas Science Laboratory, is mainly engaged in medical research and experimental development, drug clinical trial services, and third-party independent testing services. Recently, Texas Science Laboratory obtained the CLIA certification certificate issued by the Centers for Medicare and Medicaid Services of the United States, valid until August 10, 2026. The laboratory that obtained this certificate can accept patient samples and conduct sample analysis during the validity period of the certificate.

Chengdu Easton Biopharmaceuticals: Propiverine Hydrochloride Oral Solution and others obtain drug registration certificates

Yuan Dong Bio announced that its wholly-owned subsidiary, Shuo De Pharmaceuticals, obtained the drug registration certificate for Propylcatinone Hydrochloride Oral Solution and Fluvastamine Maleate Tablets. The main component of Propylcatinone Hydrochloride Oral Solution is propylcatinone hydrochloride, which is indicated for the relief of respiratory symptoms such as breathing difficulties caused by obstructive airway disorders, such as bronchial asthma. The main component of Fluvastamine Maleate Tablets is fluvastamine maleate, which is indicated for depression and obsessive-compulsive disorders.

Shenzhou Cell: Its holding subsidiary, SCT, received the Notice of Approval for Drug Clinical Trials for its product SCT520FF.

Shenzhou Cell announced that its holding subsidiary, Shenzhou Cell Engineering Co., Ltd., received the Notice of Approval for Drug Clinical Trials issued by the National Medical Products Administration, approving its product SCT520FF Injection for clinical trials in the treatment of age-related macular degeneration caused by neovascularization. SCT520FF is a self-developed anti-angiogenesis biologic drug by the company. However, the results and timing of clinical trials, reviews, and approvals are uncertain. Investors should make cautious decisions and be aware of investment risks. It is expected that there will be no significant impact on the company's business performance in the short term.

Chengda Biotech: The application for the registration of the production of pharmaceuticals for lyophilized human rabies vaccine has been accepted.

Chengda Bio announced that its wholly-owned subsidiary, Chengda Bio (Benxi) Co., Ltd., has obtained the 'Notice of Acceptance' of the application for the domestic production drug registration of the human diploid cell rabies vaccine. The product uses human diploid cells as the matrix for cultivation, with advanced production technology and stable quality, and has good safety and immunogenicity. If approved for sale in the future, it will enrich the company's product pipeline, enhance its core competitiveness, and have a positive impact on the company's business performance. However, there is uncertainty in the progress of the review and approval, as well as the time to obtain the drug registration certificate for production.

Venture Capital Wind Vane

Infinigence AI announced the completion of nearly 0.5 billion yuan in Series A financing.

Infinigence AI announced the completion of nearly 0.5 billion yuan in Series A financing. Within one year and four months of its establishment, Infinigence AI has completed nearly 1 billion yuan in financing. The lead investors in this round of financing for Infinigence AI are the Social Security Fund Center for Independent Innovation (Zhongguancun), Qiming Venture Partners, and Hongtai Fund, with follow-on investments from Lenovo Capital, Xiaomi, and Neusoft High-Tech. It is understood that the funds raised in this round of financing will be used to strengthen the recruitment of technical talents and technology research and development, promote the commercial development of products, and serve as a 'super amplifier' for AI model computing power.

Carbon Language New Materials Completes Pre-A Round of Financing

Recently, Guangdong Carbon Language New Materials Co., Ltd. (Carbon Language New Materials) announced the completion of the Pre-A round of financing, with investment from Sino Capital and Guozhong Chuangtou. This round of financing will be used for the research and development, production, and application of lithium battery separator coating materials, metal organic framework materials (MOFs), and nanocarbon materials, to provide new material solutions for multiple industries including lithium batteries, petrochemicals, and gas industries. Carbon Language New Materials was established at the end of 2022 and has previously completed angel and angel+ rounds of financing.

Zneng Energy Storage Completes Approximately 100 Million Yuan A Round Financing

Recently, Zneng Energy Storage, a large-scale component developer and producer of perovskite solar cells, completed an A round of financing of approximately 100 million yuan. This round of financing was led by Wuxi Jintou and Huaxin Group, and the funds will be used to further promote the company's development in perovskite solar cell technology research, production, and technical services. Zneng Energy Storage was established in December 2021, focusing on the full range of production line equipment for thin-film photovoltaic devices (perovskite/OPV) and related equipment, as well as the development and production of key components for photovoltaic panels.

Yinghe Yimai Completes Angel Round of Financing of Tens of Millions of RMB

Recently, the medical image AI provider Yinghe Yimai announced the completion of a tens of millions of RMB angel round of financing, with the investment from well-known investment institution Zhongjin Capital. Yinghe Yimai is committed to providing medical image assistant tools based on AI and statistical methods for imaging doctors. The company has a strong foundation in medical and technology expertise, and its founding team members are top imaging medical experts and big data and AI experts in China and North America. This round of financing will be used to further promote product research and development, market expansion, and team building. Prior to this, Yinghe Yimai had completed a seed round of financing.